Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.7230
-0.0170 (-2.30%)
At close: Mar 27, 2026, 4:00 PM EDT
0.7339
+0.0109 (1.51%)
After-hours: Mar 27, 2026, 7:46 PM EDT
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $4.87 million as of March 27, 2026. Its market cap has increased by 274.47% in one year.
Market Cap
4.87M
Enterprise Value
-12.42M
1-Year Change
274.47%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $257.00M to $4.87M, a decrease of -98.11%. That is a compound annual growth rate of -36.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 5.50M | -23.61% |
| Dec 31, 2025 | 7.20M | -15.29% |
| Dec 31, 2024 | 8.50M | -31.45% |
| Dec 29, 2023 | 12.40M | -70.75% |
| Dec 30, 2022 | 42.40M | -72.66% |
| Dec 31, 2021 | 155.10M | -37.18% |
| Dec 31, 2020 | 246.90M | 49.18% |
| Dec 31, 2019 | 165.50M | 106.36% |
| Dec 31, 2018 | 80.20M | -74.50% |
| Dec 29, 2017 | 314.50M | 22.37% |
| Aug 22, 2017 | 257.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Psyence Biomedical | 5.76M |
| Alzamend Neuro | 5.71M |
| Quince Therapeutics | 5.67M |
| Pulmatrix | 5.62M |
| Aspire Biopharma Holdings | 5.58M |
| Liminatus Pharma | 5.37M |
| Silo Pharma | 5.11M |
| Moolec Science | 5.11M |